Ultragenyx Pharmaceutical
RARE
RARE
158 hedge funds and large institutions have $3.75B invested in Ultragenyx Pharmaceutical in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 27 closing their positions.
Holders
158
Holders Change
-7
Holders Change %
-4.24%
% of All Funds
3.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
54
Reduced
57
Closed
27
Calls
$13.2M
Puts
$14.2M
Net Calls
-$1.06M
Net Calls Change
+$7.52M
Top Buyers
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$266M |
| 2 |
PAMU
2
Pictet Asset Management (UK)
London,
United Kingdom
|
$49.3M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$127M |
| 4 |
4
Norges Bank
Oslo,
Norway
|
$42.8M |
| 5 |
5
Goldman Sachs
New York
|
$18.7M |